Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.

Deweindt C, Albagli O, Bernardin F, Dhordain P, Quief S, Lantoine D, Kerckaert JP, Leprince D.

Cell Growth Differ. 1995 Dec;6(12):1495-503.

2.

Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1.

Bohmann D, Bos TJ, Admon A, Nishimura T, Vogt PK, Tjian R.

Science. 1987 Dec 4;238(4832):1386-92. Review.

PMID:
2825349
3.

Internal deletions within the BCL6 gene in B-cell non-Hodgkin's lymphoma.

Nakamura Y.

Leuk Lymphoma. 2000 Aug;38(5-6):505-12. Review.

PMID:
10953971
4.

Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.

Jardin F, Sahota SS.

Hematology. 2005 Apr;10(2):115-29. Review.

PMID:
16019457
5.
6.

BCL-6 in diffuse large-cell lymphomas.

Dalla-Favera R, Ye BH, Cattoretti G, Lo Coco F, Chang CC, Zhang J, Migliazza A, Cechova K, Niu H, Chaganti S, Chen W, Louie DC, Offit K, Chaganti RS.

Important Adv Oncol. 1996:139-48. Review. No abstract available.

PMID:
8791133
7.

Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6.

Pasqualucci L, Bereshchenko O, Niu H, Klein U, Basso K, Guglielmino R, Cattoretti G, Dalla-Favera R.

Leuk Lymphoma. 2003;44 Suppl 3:S5-12. Review. Erratum in: Leuk Lymphoma. 2013 May;54(5):1121. Bereschenko, Oxana [corrected to Bereshchenko, Oxana].

PMID:
15202519
8.

jun: oncogene and transcription factor.

Vogt PK, Bos TJ.

Adv Cancer Res. 1990;55:1-35. Review. No abstract available.

PMID:
2166997
9.

The ETS-domain transcription factor family.

Sharrocks AD, Brown AL, Ling Y, Yates PR.

Int J Biochem Cell Biol. 1997 Dec;29(12):1371-87. Review.

PMID:
9570133
10.

Implication of HIC1 (Hypermethylated In Cancer 1) in the DNA damage response.

Dehennaut V, Leprince D.

Bull Cancer. 2009 Nov;96(11):E66-72. doi: 10.1684/bdc.2009.0959. Review.

11.

Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.

Parekh S, Privé G, Melnick A.

Leuk Lymphoma. 2008 May;49(5):874-82. doi: 10.1080/10428190801895345. Review.

12.

Oncogenes and transcriptional control.

Varmus HE.

Science. 1987 Dec 4;238(4832):1337-9. Review. No abstract available.

PMID:
2825348
13.

BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis.

Basso K, Dalla-Favera R.

Adv Immunol. 2010;105:193-210. doi: 10.1016/S0065-2776(10)05007-8. Review.

PMID:
20510734
14.

Functional analysis of the role of POK transcriptional repressors.

Costoya JA.

Brief Funct Genomic Proteomic. 2007 Mar;6(1):8-18. Epub 2007 Mar 24. Review.

PMID:
17384421
15.

The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.

Jardin F, Ruminy P, Bastard C, Tilly H.

Pathol Biol (Paris). 2007 Feb;55(1):73-83. Epub 2006 Jul 3. Review.

PMID:
16815642
17.

A role for Kaiso-p120ctn complexes in cancer?

van Roy FM, McCrea PD.

Nat Rev Cancer. 2005 Dec;5(12):956-64. Review.

PMID:
16294216
18.

Gfi1 and Gfi1b: key regulators of hematopoiesis.

van der Meer LT, Jansen JH, van der Reijden BA.

Leukemia. 2010 Nov;24(11):1834-43. doi: 10.1038/leu.2010.195. Epub 2010 Sep 23. Review.

PMID:
20861919
19.

Hematopoietic transcriptional regulation by the myeloid zinc finger gene, MZF-1.

Hromas R, Davis B, Rauscher FJ 3rd, Klemsz M, Tenen D, Hoffman S, Xu D, Morris JF.

Curr Top Microbiol Immunol. 1996;211:159-64. Review.

PMID:
8585946
20.

Pathogenetic role of BCL6 translocation in B-cell non-Hodgkin's lymphoma.

Ohno H.

Histol Histopathol. 2004 Apr;19(2):637-50. doi: 10.14670/HH-19.637. Review.

PMID:
15024721

Supplemental Content

Support Center